ETMarkets Smart Talk- We expect IT and pharma to do well amid attractive valuations: Kedar Kadam
“We expect yesterday’s underperformers to be winners of tomorrow, i.e. IT and Pharma. The valuations are very attractive from a ...
“We expect yesterday’s underperformers to be winners of tomorrow, i.e. IT and Pharma. The valuations are very attractive from a ...
Signage for Eisai Co. at the company's headquarters in Tokyo, Japan, on Friday, Feb. 3, 2023.Bloomberg | Bloomberg | Getty ...
Mankind Pharma, a recent entrant to the stock exchanges, has been included in several Nifty indices, including Nifty500, Nifty Midcap150, ...
iQoncept Buoyed by booming sales of its diabetes drugs, Eli Lilly (NYSE:LLY) was the best performing large pharma or biotech ...
Brokerage firms such as Jefferies initiated a hold rating on Mankind Pharma, Bernstein upgraded Delhivery to outperform, ICICI Securities initiated ...
Abhishek Basumallick, Chief Investment Adviser, Intelsense Capital, says “the problem with IT, especially IT services, is that until and unless ...
Indian market is expected to consolidate on Wednesday tracking positive global cues. The S&P BSE Sensex and Nifty50 closed flat ...
Infosys, NTPC and Hindustan Unilever were among the top large-cap stocks fancied by mutual funds in April, while reducing positions ...
Zarina Lukash/iStock via Getty Images Astellas Pharma Inc. (OTCPK:ALPMF) agreed to acquire Iveric Bio (NASDAQ:ISEE) for $5.9 billion to add ...
The initial share sale of Mankind Pharma will open for subscription on Tuesday and will be available for public to ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.